Senolytics Restore Sickle Cell Stem-Cell Fitness

Company St. Jude Children’s Research Hospital Event Type Preclinical Research Findings Modality Senolytic Combination / HSC Fitness Optimization Asset Dasatinib + Quercetin (Senolytic Combination) Target Senescent Hematopoietic Stem Cells Disease Area Sickle Cell Disease (Autologous Gene Therapy Manufacturing) Summary St. Jude researchers found that hematopoietic…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *